Titan Pharmaceuticals Company Profile (OTCMKTS:TTNP)

About Titan Pharmaceuticals

Titan Pharmaceuticals logoTitan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: TTNP
  • CUSIP:
Key Metrics:
  • Previous Close: $5.47
  • 50 Day Moving Average: $5.15
  • 200 Day Moving Average: $5.17
  • Trailing P/E Ratio: 18.48
  • Foreward P/E Ratio: -15.83
  • P/E Growth: 0.00
  • Market Cap: $115.95M
  • Outstanding Shares: 21,198,000
Additional Links:
Companies Related to Titan Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Titan Pharmaceuticals (OTCMKTS:TTNP) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00

Analysts' Ratings History for Titan Pharmaceuticals (OTCMKTS:TTNP)
Show:
DateFirmActionRatingPrice TargetDetails
5/29/2016Roth CapitalReiterated RatingBuy$7.75 -> $10.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Titan Pharmaceuticals (OTCMKTS:TTNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016        
8/9/2016Q216$0.56$0.58$15.00 million$15.00 millionViewN/AView Earnings Details
5/10/2016Q116($0.12)($0.09)ViewListenView Earnings Details
3/15/2016Q415($0.10)($0.11)ViewListenView Earnings Details
8/13/2015($0.02)($0.02)ViewN/AView Earnings Details
5/13/2015($0.03)($0.04)ViewN/AView Earnings Details
3/31/2015($0.01)($0.01)ViewN/AView Earnings Details
11/13/2014($0.02)($0.01)ViewN/AView Earnings Details
8/13/2014($0.02)($0.01)ViewN/AView Earnings Details
11/15/2013Q3 13($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Titan Pharmaceuticals (OTCMKTS:TTNP)
Current Year EPS Consensus Estimate: $0.25 EPS
Next Year EPS Consensus Estimate: $-0.35 EPS

Dividends

Dividend History for Titan Pharmaceuticals (OTCMKTS:TTNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Titan Pharmaceuticals (OTCMKTS:TTNP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/19/2016Joseph A AkersDirectorBuy13,000$4.85$63,050.00View SEC Filing  
7/18/2016Sunil BhonsleCEOBuy10,000$4.96$49,600.00View SEC Filing  
5/31/2016James R McnabDirectorBuy20,000$7.03$140,600.00View SEC Filing  
2/22/2016Sunil BhonsleCEOBuy11,763$3.56$41,876.28View SEC Filing  
1/15/2016Sunil BhonsleCEOBuy5,841$2.72$15,887.52View SEC Filing  
1/13/2016James R McnabDirectorBuy16,363$3.16$51,707.08View SEC Filing  
1/11/2016Marc RubinChairmanBuy5,000$3.25$16,250.00View SEC Filing  
1/11/2016Sunil BhonsleCEOBuy17,000$3.18$54,060.00View SEC Filing  
9/16/2015Sunil BhonslePresidentBuy10,000$0.70$7,000.00View SEC Filing  
8/28/2015Marc RubinChairmanBuy50,000$0.72$36,000.00View SEC Filing  
8/25/2015Sunil BhonslePresidentBuy50,000$0.70$35,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Titan Pharmaceuticals (OTCMKTS:TTNP)
DateHeadline
finance.yahoo.com logoTTNP: Probuphine Licensing: EU & Australia In the Works (OTCMKTS:TTNP)
finance.yahoo.com - August 24 at 10:58 AM
capitalcube.com logoETF’s with exposure to Titan Pharmaceuticals, Inc. : August 12, 2016 (OTCMKTS:TTNP)
www.capitalcube.com - August 12 at 8:04 PM
finance.yahoo.com logoTTNP: Probuphine Sales in 2Q:16; Provider Training On Track (OTCMKTS:TTNP)
finance.yahoo.com - August 11 at 8:34 PM
capitalcube.com logoTitan Pharmaceuticals, Inc. :TTNP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (OTCMKTS:TTNP)
www.capitalcube.com - August 11 at 11:23 AM
News IconTitan Pharma Reports Second Quarter 2016 Financial Results (OTCMKTS:TTNP)
www.biospace.com - August 9 at 8:17 PM
marketwired.com logoTitan Pharmaceuticals Reports Second Quarter 2016 Financial Results (OTCMKTS:TTNP)
www.marketwired.com - August 9 at 11:23 AM
sg.finance.yahoo.com logoTitan Pharmaceuticals posts 2Q profit (OTCMKTS:TTNP)
sg.finance.yahoo.com - August 9 at 11:23 AM
biz.yahoo.com logoTITAN PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a V (OTCMKTS:TTNP)
biz.yahoo.com - August 3 at 8:19 PM
publicnow.com logoTitan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2016 Financial Results (OTCMKTS:TTNP)
www.publicnow.com - August 3 at 11:16 AM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Las Vegas on July 29, 30 and 31 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 26 at 11:00 AM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Burlington on July 29 and 30 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 26 at 8:00 AM
4-traders.com logoThursday 7/21 Insider Buying Report: TTNP, MYCC (OTCMKTS:TTNP)
www.4-traders.com - July 22 at 10:52 AM
News IconTitan Pharmaceuticals, Inc. (NASDAQ:TTNP)'s Company Shares Decreased 22.33% After High Volatility - Consumer Eagle (OTCMKTS:TTNP)
www.consumereagle.com - July 21 at 8:17 PM
News IconStock Moving Lower for the Month; Investor Update on Titan Pharmaceuticals Inc. (:TTNP) - Engelwood Daily (OTCMKTS:TTNP)
www.engelwooddaily.com - July 20 at 9:00 PM
News IconSunil Bhonsle Purchased 10000 Shares of Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) - Consumer Eagle (OTCMKTS:TTNP)
www.consumereagle.com - July 20 at 9:00 PM
News IconTitan Pharmaceuticals, Inc. Can't Burn Your Long Portfolio. Has Another Strong Session - Press Telegraph (OTCMKTS:TTNP)
presstelegraph.com - July 20 at 9:00 PM
News IconIncreased Stock Volatility Watch: Titan Pharmaceuticals Inc. (:TTNP) - Engelwood Daily (OTCMKTS:TTNP)
www.engelwooddaily.com - July 20 at 9:00 PM
news.cmlviz.com logoTitan Pharmaceuticals Inc Stock Technicals Hit Weakness - CML News (OTCMKTS:TTNP)
news.cmlviz.com - July 20 at 9:00 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Nashville on July 22, 23 and 24 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 2:03 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Honolulu on July 22 and 23 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 2:00 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Oklahoma City on July 22, 23 and 24 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 1:43 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Houston on July 22, 23 and 24 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 1:42 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Seattle on July 22, 23 and 24 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 1:41 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in San Diego on July 22, 23 and 24 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 1:40 PM
finance.yahoo.com logoBraeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Jacksonville on July 22, 23 and 24 for Qualified Healthcare Providers (OTCMKTS:TTNP)
finance.yahoo.com - July 19 at 1:01 PM
News IconShares Moving Down on the Week: Titan Pharmaceuticals Inc. (:TTNP) - Engelwood Daily (OTCMKTS:TTNP)
www.engelwooddaily.com - July 17 at 8:55 AM
fiscalstandard.com logoTitan Pharmaceuticals, Inc. (TTNP) Current Analyst Ratings - Fiscal Standard (OTCMKTS:TTNP)
www.fiscalstandard.com - July 15 at 6:54 PM
ftsenews.co.uk logoNew Broker Ratings For Titan Pharmaceuticals, Inc. (TTNP) - FTSE News (OTCMKTS:TTNP)
www.ftsenews.co.uk - July 9 at 10:52 AM
fiscalstandard.com logoBroker Outlook For The Week Ahead Titan Pharmaceuticals, Inc. (TTNP) - Fiscal Standard (OTCMKTS:TTNP)
www.fiscalstandard.com - July 6 at 8:24 PM
News IconCompany Stock Lower on the Week Titan Pharmaceuticals Inc. (:TTNP) - Engelwood Daily (OTCMKTS:TTNP)
www.engelwooddaily.com - July 2 at 7:24 PM
biz.yahoo.com logoTITAN PHARMACEUTICALS INC Files SEC form 8-K, Other Events (OTCMKTS:TTNP)
biz.yahoo.com - July 1 at 3:40 PM
News IconUpdate on Stock Volatility for: Titan Pharmaceuticals Inc. (:TTNP) - Engelwood Daily (OTCMKTS:TTNP)
www.engelwooddaily.com - July 1 at 10:35 AM
finance.yahoo.com logoShareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Titan Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (OTCMKTS:TTNP)
finance.yahoo.com - June 30 at 9:42 AM
News IconStock Volatility in Review: Titan Pharmaceuticals Inc. (:TTNP) - Engelwood Daily (OTCMKTS:TTNP)
www.engelwooddaily.com - June 29 at 10:38 AM
ftsenews.co.uk logoTitan Pharmaceuticals, Inc. (TTNP) Updated Price Targets - FTSE News (OTCMKTS:TTNP)
www.ftsenews.co.uk - June 29 at 10:38 AM
marketwatch.com logoTitan Pharmaceuticals Added to Russell 3000 Index - MarketWatch (OTCMKTS:TTNP)
www.marketwatch.com - June 27 at 8:25 AM
publicnow.com logoTitan Pharmaceuticals Added to Russell 3000 Index (OTCMKTS:TTNP)
www.publicnow.com - June 27 at 7:11 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Titan Pharmaceuticals, Inc. (TTNP) - Fiscal Standard (OTCMKTS:TTNP)
www.fiscalstandard.com - June 24 at 7:58 PM
marketwired.com logoTitan Pharmaceuticals Announces First Patients Treated With Probuphine® for Opioid Dependence (OTCMKTS:TTNP)
www.marketwired.com - June 20 at 7:29 PM
biz.yahoo.com logoTITAN PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibi (OTCMKTS:TTNP)
biz.yahoo.com - June 20 at 4:05 PM
streetinsider.com logoTitan Pharma (TTNP) Treats First Patients with Probuphine Implant - StreetInsider.com (OTCMKTS:TTNP)
www.streetinsider.com - June 20 at 9:20 AM
fiscalstandard.com logoThis Weeks Broker Views For Titan Pharmaceuticals, Inc. (TTNP) - Fiscal Standard (OTCMKTS:TTNP)
www.fiscalstandard.com - June 20 at 9:20 AM
finance.yahoo.com logoTitan Pharmaceuticals Announces First Patients Treated With Probuphine(R) for Opioid Dependence (OTCMKTS:TTNP)
finance.yahoo.com - June 20 at 8:15 AM
marketwired.com logoTitan Pharmaceuticals Announces Rigorous Sensitivity Analyses Confirm Effectiveness of Probuphine® for Opioid Dependence (OTCMKTS:TTNP)
www.marketwired.com - June 16 at 11:13 AM
finance.yahoo.com logoProbuphine® (buprenorphine) Implant Phase 3 Data Presented at CPDD Annual Scientific Meeting (OTCMKTS:TTNP)
finance.yahoo.com - June 16 at 9:30 AM
streetinsider.com logoTitan Pharma (TTNP) Will Present Four Post-Hoc Analyses from Probuphine Phase 3 in Opioid Dependence - StreetInsider.com (OTCMKTS:TTNP)
www.streetinsider.com - June 15 at 8:46 AM
publicnow.com logoTitan Pharmaceuticals Announces Rigorous Sensitivity Analyses Confirm Effectiveness of Probuphine(R) for Opioid Dependence (OTCMKTS:TTNP)
www.publicnow.com - June 15 at 7:19 AM
marketwired.com logoTitan Pharmaceuticals Receives $15 Million Milestone Payment Following FDA Approval of Probuphine® (OTCMKTS:TTNP)
www.marketwired.com - June 13 at 10:53 AM
publicnow.com logoTitan Pharmaceuticals Receives $15 Million Milestone Payment Following FDA Approval of Probuphine(R) (OTCMKTS:TTNP)
www.publicnow.com - June 13 at 7:09 AM
istreetwire.com logoTitan Pharmaceuticals Inc. (NASDAQ:TTNP) Earnings Preview: Should Investors Be Nervous? - iStreetWire (OTCMKTS:TTNP)
istreetwire.com - June 9 at 8:29 PM

Social

Titan Pharmaceuticals (OTCMKTS:TTNP) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff